Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 2, 2006
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology
Richard T Hoppe, Ranjana Hira Advani, Philip J Bierman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494
Jane N Winter, Shuli Li, Vikas Aurora, et al.
Blood
|
November 23, 2013
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou, Laurie H Sehn, Alfred W Rademaker, et al.
Cancer
|
March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
Chi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma
Stephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Blood Advances
|
March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Megan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Bcl-B expression in human epithelial and nonepithelial malignancies
Maryla Krajewska, Shinichi Kitada, Jane N Winter, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood Advances
|
November 18, 2022
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Yong Li, Zijun Y Xu-Monette, Jeremy Abramson, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 2, 2006
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology
Richard T Hoppe, Ranjana Hira Advani, Philip J Bierman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494
Jane N Winter, Shuli Li, Vikas Aurora, et al.
Blood
|
November 23, 2013
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou, Laurie H Sehn, Alfred W Rademaker, et al.
Cancer
|
March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program
Chi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma
Stephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Blood Advances
|
March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Megan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Bcl-B expression in human epithelial and nonepithelial malignancies
Maryla Krajewska, Shinichi Kitada, Jane N Winter, et al.
Leukemia & Lymphoma
|
January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis
Zeina Al-Mansour, Hongli Li, James R Cook, et al.
The New England Journal of Medicine
|
November 1, 2013
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma
Patrick J Stiff, Joseph M Unger, James R Cook, et al.
Blood Advances
|
November 18, 2022
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Yong Li, Zijun Y Xu-Monette, Jeremy Abramson, et al.
Page
of 15